Literature DB >> 10025723

Light and electron microscopic immunohistochemical observations of p75 nerve growth factor receptor-immunoreactive dermal nerves in prurigo nodularis.

Y Liang1, J A Marcusson, O Johansson.   

Abstract

Prurigo nodularis is an inflammatory skin disease characterized by neurohyperplasia. Neurotrophins and their receptors play a critical role in nerve growth, differentiation, maturation and maintenance, including cutaneous nerve fiber growth and innervation. They may also be responsible for events related to the growth and differentiation control of keratinocytes. To explore the exact distribution of the p75 low-affinity nerve growth factor receptor (p75 NGFr) in the cutaneous nerve components, p75 NGFr immunofluorescence as well as ultrastructural immunohistochemical studies were performed on prurigo nodularis lesional skin and normal human skin samples. The immunofluorescence results revealed that nerve fibers and bundles were increased in number and size in lesional upper dermis with stronger p75 NGFr immunoreactivity than in the corresponding normal tissue. At the ultrastructural level, a lot of nerve fibers clustered together in the prurigo nodularis dermal tissue. The axons were enlarged and branched, but the axons themselves seldom showed any NGFr immunoreactivity. The Schwann cell bodies were extended and irregularly shaped, and tended to separate into many branches enveloping the axons. The Schwann cell membrane showed strong p75 NGFr immunoreactivity. The perineurium cells also revealed strong p75 NGFr immunoreactivity. The Schwann cells inside the perineurium were less p75 NGFr-immunoreactive than those outside the perineurium. The membrane of certain basal keratinocytes showed NGFr immunoreactivity as well. The present results indicate that overexpression of p75 NGFr in Schwann cells and perineurium cells could contribute to the neurohyperplasia in prurigo nodularis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10025723     DOI: 10.1007/s004030050378

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  7 in total

1.  Treatment of spinal cord injury with co-grafts of genetically modified Schwann cells and fetal spinal cord cell suspension in the rat.

Authors:  Shi-Qing Feng; Xiao-Hong Kong; Shi-Fu Guo; Pei Wang; Li Li; Jin-Hua Zhong; Xin-Fu Zhou
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 2.  [Neurophysiology of pruritus].

Authors:  U Raap; A Ikoma; A Kapp
Journal:  Hautarzt       Date:  2006-05       Impact factor: 0.751

3.  Altered cutaneous nerve regeneration in a simian immunodeficiency virus / macaque intracutaneous axotomy model.

Authors:  Gigi J Ebenezer; Victoria A Laast; Brandon Dearman; Peter Hauer; Patrick M Tarwater; Robert J Adams; M Christine Zink; Justin C McArthur; Joseph L Mankowski
Journal:  J Comp Neurol       Date:  2009-05-20       Impact factor: 3.215

4.  Dynamic mechanical allodynia following finger amputation: Unexpected skin hyperinnervation.

Authors:  Michelangelo Buonocore; Maria Concetta Gagliano; Cesare Bonezzi
Journal:  World J Clin Cases       Date:  2013-09-16       Impact factor: 1.337

5.  Human dermis harbors distinct mesenchymal stromal cell subsets.

Authors:  Christine Vaculik; Christopher Schuster; Wolfgang Bauer; Nousheen Iram; Karin Pfisterer; Gero Kramer; Andreas Reinisch; Dirk Strunk; Adelheid Elbe-Bürger
Journal:  J Invest Dermatol       Date:  2011-11-03       Impact factor: 8.551

6.  Exosomes Derived From Umbilical Cord Mesenchymal Stem Cells Treat Cutaneous Nerve Damage and Promote Wound Healing.

Authors:  Ziying Zhu; Xiaona Zhang; Haojie Hao; Heran Xu; Jun Shu; Qian Hou; Min Wang
Journal:  Front Cell Neurosci       Date:  2022-06-30       Impact factor: 6.147

7.  Oral ketotifen and topical antibiotic therapy in the management of pruritus in prurigo nodularis: a randomized, controlled, single-blind, parallel study.

Authors:  Ashimav Deb Sharma
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.